Analgesic nephropathy: clinical features and pathogenesis. Original data on the incidence and prevalence in a single renal unit.
Lornoy
W
W
Renal Unit and Central Laboratory, O.L. Vrouwziekenhuis, Aalst, Belgium.
Becaus
I
I
Billiouw
J M
JM
Sierens
L
L
D000328:Adult; D000367:Age Factors; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D003952:Diagnostic Imaging; D004338:Drug Combinations; D005260:Female; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000209:etiology; D007680:Kidney Neoplasms / Q000209:etiology; D007681:Kidney Papillary Necrosis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000209:etiology; D010615:Phenacetin / Q000008:administration & dosage / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects; D047069:Pyrazolones; D006435:Renal Dialysis
D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D011720:Pyrazoles; D047069:Pyrazolones; C038362:pyrazolone; D010615:Phenacetin; D001241:Aspirin